Chris FCCPGlobal Compound Development Team Leader (CDTL), tesnatilimab (JnJ4500)
Wilmington, Delaware
Global Compound Development Team Leader (CDTL), tesnatilimab (JnJ4500)
Global Therapeutic Area Clinical Director/Head (TACD), Late Phase R/I Drug Development (RITA)
Associate Director/Director/Senior Director
Head, Pulmonary Clinical Development 2014-2016
Head, Gastrenterology Late Phase Clinical Development, 2015-2019
Instructor of Medicine
Adjunct Clinical Assistant Professor
Global Medical Science Director/Executive Director, Drug Development
Vice President, Global Respiratory R/D
University of Pennsylvania, Graduate School, Cell and Molecular Biology
University of Pennsylvania School of Medicine, HUP
University of Pennsylvania School of Medicine, HUP
Recommendations: 0
Drug Development
Medical Affairs
Clinical Development
Pharmaceutical Industry
Clinical Trials
Lifesciences
Biotechnology
Therapeutic Areas